Acumen Pharmaceuticals (ABOS) Gains from Investment Securities (2022 - 2025)
Acumen Pharmaceuticals recorded quarterly Gains from Investment Securities of $56000.0 in Q4 2025, up 300.0% quarter-over-quarter from $14000.0 in Q3 2025, and up 275.0% year-over-year from $14933.3 in Q4 2024.
Acumen Pharmaceuticals' Gains from Investment Securities history runs 3 years deep, the most recent figure standing at $56000.0 for Q4 2025.
- In Q4 2025, Gains from Investment Securities rose 275.0% year-over-year to $56000.0; the TTM figure through Dec 2025 stood at $73000.0 (up 3750.0% YoY), while the FY2025 annual figure was $73000.0, changed N/A from the prior year.
- Gains from Investment Securities came in at $56000.0 for Q4 2025 at Acumen Pharmaceuticals, up from $14000.0 in the prior quarter.
- In the past five years, Gains from Investment Securities ranged from a high of $73000.0 in Q1 2025 to a low of -$233000.0 in Q4 2022.
- A 3-year average of -$23142.9 and a median of $14000.0 in 2025 frame the typical range for Gains from Investment Securities.
- On a YoY basis, Gains from Investment Securities climbed as much as 275.0% in 2025 and fell as far as 53.33% in 2025.
- Acumen Pharmaceuticals' Gains from Investment Securities stood at -$233000.0 in 2022, then soared by 86.27% to -$32000.0 in 2024, then jumped by 275.0% to $56000.0 in 2025.
- According to Business Quant data, Gains from Investment Securities over the past three periods registered $56000.0, $14000.0, and -$70000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Acumen Pharmaceuticals | 164.37 Mn | 35.97 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 56,000.00 |
| Dec 31, 2025 | 56,000.00 |
| Sep 30, 2025 | 14,000.00 |
| Sep 30, 2025 | 14,000.00 |
| Jun 30, 2025 | -70,000.00 |
| Jun 30, 2025 | -70,000.00 |
| Mar 31, 2025 | 73,000.00 |
| Mar 31, 2025 | 73,000.00 |
| Dec 31, 2024 | -32,000.00 |
| Dec 31, 2024 | -32,000.00 |
| Sep 30, 2024 | 30,000.00 |
| Sep 30, 2024 | 30,000.00 |
| Dec 31, 2022 | -233,000.00 |
| Dec 31, 2022 | -233,000.00 |